Table 2 CGM monitored blood profiles in study subjects.

From: Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values

Items

L Group

M Group

H Group

24-hrs MG (mmol/L)

9.46 ± 1.85

11.47 ± 2.19a**

13.52 ± 2.20ab**

SDMG (mmol/L)

2.00 ± 0.79

2.55 ± 0.90a**

2.88 ± 0.99a**b*

MAGE (mmol/L)

5.20 ± 2.35

6.30 ± 2.38a*

7.44 ± 3.00a**b*

AUC (<3.9 mmol/L*Day)

0.01 ± 0.07

0.00 ± 0.01

0.00 ± 0.03

AUC (>10.0 mmol/L*Day)

0.80 ± 0.93

2.18 ± 1.57a**

3.76 ± 1.90ab**

PG (mmol/L)

13.23 ± 3.49

16.27 ± 3.62a**

18.63 ± 2.98 a**b**

Time to peak (min)

91.36 ± 31.01

82.94 ± 26.54

108.00 ± 30.19ab*

  1. Data are presented as the means ± SD. L Group: Lower HbA1c values group, M Group: Moderate HbA1c values group, H Group: higher HbA1c values group, a*compared with the L Group (P < 0.05), a**compared with M Group (P < 0.01), b*compared with M Group (P < 0.05), b**compared with M Group (P <  < 0.01), ab**compared with the L and M Groups (P < 0.01), ab*compared with the L and M Groups (P < 0.05), 24-hr MG: 24-hr mean glucose concentrations, SDMG: 24-hr standard deviation of MG, AUC: the incremental area under the curve, PG: peak glucose concentrations.